Effectiveness of a second BNT162b2 booster vaccine against hospitalization and death from COVID-19 in adults aged over 60 years
Ronen Arbel, Ruslan Sergienko, Michael Friger, Alon Peretz, Tanya Beckenstein, Shlomit Yaron, Doron Netzer, Ariel Hammerman
Topics & Concepts
Booster (rocketry)MedicineHazard ratioBooster doseConfidence intervalCoronavirus disease 2019 (COVID-19)Proportional hazards modelCohortRetrospective cohort studyPediatricsInternal medicineDiseaseInfectious disease (medical specialty)VirologyVirusAstronomyTiterPhysicsSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies